HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A.

Abstract
The pathogenicity of Clostridium difficile is due to the production of two toxins (toxins A and B). We prepared monoclonal antibodies against toxin A and determined whether axenic mice passively immunized with the monoclonal antibodies were protected against C. difficile disease. The mice were kept in an isolator and were given ascites fluid intravenously prior to challenge with a toxinogenic strain of C. difficile. Control mice and mice receiving ascites fluid devoid of toxin antibody died within 2 days and had high levels of toxins A and B in their feces. Mice that received ascites fluid containing high amounts of toxin A monoclonal antibodies directed against the repeating units of the toxin survived. In protected mice, toxin B levels were similar to those in dying mice, but toxin A levels were greatly reduced. These data show that passive immunity induced by monoclonal antibodies against toxin A was effective against pseudomembranous cecitis.
AuthorsG Corthier, M C Muller, T D Wilkins, D Lyerly, R L'Haridon
JournalInfection and immunity (Infect Immun) Vol. 59 Issue 3 Pg. 1192-5 (Mar 1991) ISSN: 0019-9567 [Print] United States
PMID1900059 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Bacterial
  • Antibodies, Monoclonal
  • Bacterial Toxins
  • Enterotoxins
  • tcdA protein, Clostridium difficile
Topics
  • Animals
  • Antibodies, Bacterial (immunology)
  • Antibodies, Monoclonal (administration & dosage)
  • Ascitic Fluid (immunology)
  • Bacterial Toxins (administration & dosage, immunology)
  • Clostridioides difficile (immunology)
  • Enterocolitis, Pseudomembranous (mortality, prevention & control)
  • Enterotoxins
  • Germ-Free Life
  • Immunization, Passive
  • Mice
  • Mice, Inbred C3H
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: